Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 417

1.

Pharmacokinetic analysis of [68Ga]Ga-DOTA-TOC PET in meningiomas for assessment of in vivo somatostatin receptor subtype 2.

Bashir A, Vestergaard MB, Binderup T, Broholm H, Marner L, Ziebell M, Fugleholm K, Mathiesen T, Kjær A, Law I.

Eur J Nucl Med Mol Imaging. 2020 Mar 13. doi: 10.1007/s00259-020-04759-1. [Epub ahead of print]

PMID:
32170347
2.

64Cu-DOTATATE PET/CT and prediction of overall and progression-free survival in patients with neuroendocrine neoplasms.

Carlsen EA, Johnbeck CB, Binderup T, Loft M, Pfeifer A, Mortensen J, Oturai P, Loft A, Berthelsen AK, Langer SW, Knigge U, Kjaer A.

J Nucl Med. 2020 Feb 28. pii: jnumed.119.240143. doi: 10.2967/jnumed.119.240143. [Epub ahead of print]

PMID:
32111685
3.

Monitoring CD8a+ T Cell Responses to Radiotherapy and CTLA-4 Blockade Using [64Cu]NOTA-CD8a PET Imaging.

Kristensen LK, Christensen C, Alfsen MZ, Cold S, Nielsen CH, Kjaer A.

Mol Imaging Biol. 2020 Feb 21. doi: 10.1007/s11307-020-01481-0. [Epub ahead of print]

PMID:
32086762
4.

Diffusion weighted magnetic resonance imaging (DW-MRI) as a non-invasive, tissue cellularity marker to monitor cancer treatment response.

Fliedner FP, Engel TB, El-Ali HH, Hansen AE, Kjaer A.

BMC Cancer. 2020 Feb 19;20(1):134. doi: 10.1186/s12885-020-6617-x.

5.

In vivo imaging of cell proliferation in meningioma using 3'-deoxy-3'-[18F]fluorothymidine PET/MRI.

Bashir A, Binderup T, Vestergaard MB, Broholm H, Marner L, Ziebell M, Fugleholm K, Kjær A, Law I.

Eur J Nucl Med Mol Imaging. 2020 Feb 11. doi: 10.1007/s00259-020-04704-2. [Epub ahead of print]

PMID:
32047966
6.

Relation of cardiac adipose tissue to coronary calcification and myocardial microvascular function in type 1 and type 2 diabetes.

Zobel EH, Christensen RH, Winther SA, Hasbak P, Hansen CS, von Scholten BJ, Holmvang L, Kjaer A, Rossing P, Hansen TW.

Cardiovasc Diabetol. 2020 Feb 10;19(1):16. doi: 10.1186/s12933-020-0995-x.

7.

Evaluation of a 68Ga-Labeled DOTA-Tetrazine as a PET Alternative to 111In-SPECT Pretargeted Imaging.

Edem PE, Jørgensen JT, Nørregaard K, Rossin R, Yazdani A, Valliant JF, Robillard M, Herth MM, Kjaer A.

Molecules. 2020 Jan 22;25(3). pii: E463. doi: 10.3390/molecules25030463.

8.

64Cu-DOTATATE PET/CT for Imaging Patients with Known or Suspected Somatostatin Receptor-Positive Neuroendocrine Tumors: Results of the First US Prospective, Reader-Blinded Clinical Trial.

Delpassand ES, Ranganathan D, Wagh N, Shafie A, Gaber A, Abbasi A, Kjaer A, Tworowska I, Núñez R.

J Nucl Med. 2020 Jan 10. pii: jnumed.119.236091. doi: 10.2967/jnumed.119.236091. [Epub ahead of print]

PMID:
31924723
9.

P53, Somatostatin receptor 2a and Chromogranin A immunostaining as prognostic markers in high grade gastroenteropancreatic neuroendocrine neoplasms.

Nielsen K, Binderup T, Langer SW, Kjaer A, Knigge P, Grøndahl V, Melchior L, Federspiel B, Knigge U.

BMC Cancer. 2020 Jan 10;20(1):27. doi: 10.1186/s12885-019-6498-z.

10.

Quantitative PET imaging of PD-L1 expression in xenograft and syngeneic tumour models using a site-specifically labelled PD-L1 antibody.

Christensen C, Kristensen LK, Alfsen MZ, Nielsen CH, Kjaer A.

Eur J Nucl Med Mol Imaging. 2020 May;47(5):1302-1313. doi: 10.1007/s00259-019-04646-4. Epub 2019 Dec 27.

11.

Trans-Cyclooctene-Functionalized PeptoBrushes with Improved Reaction Kinetics of the Tetrazine Ligation for Pretargeted Nuclear Imaging.

Stéen EJL, Jørgensen JT, Johann K, Nørregaard K, Sohr B, Svatunek D, Birke A, Shalgunov V, Edem PE, Rossin R, Seidl C, Schmid F, Robillard MS, Kristensen JL, Mikula H, Barz M, Kjær A, Herth MM.

ACS Nano. 2020 Jan 28;14(1):568-584. doi: 10.1021/acsnano.9b06905. Epub 2020 Jan 2.

12.

Design of a randomised controlled trial of the effects of empagliflozin on myocardial perfusion, function and metabolism in type 2 diabetes patients at high cardiovascular risk (the SIMPLE trial).

Jürgens M, Schou M, Hasbak P, Kjær A, Wolsk E, Zerahn B, Wiberg M, Brandt NH, Gæde PH, Rossing P, Faber J, Inzucchi S, Gustafsson F, Kistorp CM.

BMJ Open. 2019 Nov 27;9(11):e029098. doi: 10.1136/bmjopen-2019-029098.

13.

CD4+ and CD8a+ PET imaging predicts response to novel PD-1 checkpoint inhibitor: studies of Sym021 in syngeneic mouse cancer models.

Kristensen LK, Fröhlich C, Christensen C, Melander MC, Poulsen TT, Galler GR, Lantto J, Horak ID, Kragh M, Nielsen CH, Kjaer A.

Theranostics. 2019 Oct 18;9(26):8221-8238. doi: 10.7150/thno.37513. eCollection 2019.

14.

No changes in myocardial perfusion following radiation therapy of left-sided breast cancer: A positron emission tomography study.

Rasmussen T, Kjær A, Lassen ML, Pedersen AN, Specht L, Aznar MC, Hasbak P.

J Nucl Cardiol. 2019 Nov 18. doi: 10.1007/s12350-019-01949-9. [Epub ahead of print]

PMID:
31741325
15.

Improved surgical resection of metastatic pancreatic cancer using uPAR targeted in vivo fluorescent guidance: comparison with traditional white light surgery.

Juhl K, Christensen A, Rubek N, Karnov KKS, von Buchwald C, Kjaer A.

Oncotarget. 2019 Oct 29;10(59):6308-6316. doi: 10.18632/oncotarget.27220. eCollection 2019 Oct 29.

16.

Proteomics-Based Comparative Mapping of the Secretomes of Human Brown and White Adipocytes Reveals EPDR1 as a Novel Batokine.

Deshmukh AS, Peijs L, Beaudry JL, Jespersen NZ, Nielsen CH, Ma T, Brunner AD, Larsen TJ, Bayarri-Olmos R, Prabhakar BS, Helgstrand C, Severinsen MCK, Holst B, Kjaer A, Tang-Christensen M, Sanfridson A, Garred P, Privé GG, Pedersen BK, Gerhart-Hines Z, Nielsen S, Drucker DJ, Mann M, Scheele C.

Cell Metab. 2019 Nov 5;30(5):963-975.e7. doi: 10.1016/j.cmet.2019.10.001. Epub 2019 Oct 24.

PMID:
31668873
17.

FDG-PET/CT in the surveillance of head and neck cancer following radiotherapy.

Risør LM, Loft A, Berthelsen AK, Loft FC, Madsen AR, Vogelius IR, Kjær A, Friborg J.

Eur Arch Otorhinolaryngol. 2020 Feb;277(2):539-547. doi: 10.1007/s00405-019-05684-2. Epub 2019 Oct 23.

PMID:
31646385
18.

Distinct Chemotaxis Protein Paralogs Assemble into Chemoreceptor Signaling Arrays To Coordinate Signaling Output.

O'Neal L, Gullett JM, Aksenova A, Hubler A, Briegel A, Ortega D, Kjær A, Jensen G, Alexandre G.

mBio. 2019 Sep 24;10(5). pii: e01757-19. doi: 10.1128/mBio.01757-19.

19.

One-Step Synthesis of N-Succinimidyl-4-[18F]Fluorobenzoate ([18F]SFB).

Nymann Petersen I, Madsen J, Bernard Matthijs Poulie C, Kjær A, Manfred Herth M.

Molecules. 2019 Sep 22;24(19). pii: E3436. doi: 10.3390/molecules24193436.

20.

Imaging-assisted nanoimmunotherapy for atherosclerosis in multiple species.

Binderup T, Duivenvoorden R, Fay F, van Leent MMT, Malkus J, Baxter S, Ishino S, Zhao Y, Sanchez-Gaytan B, Teunissen AJP, Frederico YCA, Tang J, Carlucci G, Lyashchenko S, Calcagno C, Karakatsanis N, Soultanidis G, Senders ML, Robson PM, Mani V, Ramachandran S, Lobatto ME, Hutten BA, Granada JF, Reiner T, Swirski FK, Nahrendorf M, Kjaer A, Fisher EA, Fayad ZA, Pérez-Medina C, Mulder WJM.

Sci Transl Med. 2019 Aug 21;11(506). pii: eaaw7736. doi: 10.1126/scitranslmed.aaw7736.

PMID:
31434756

Supplemental Content

Loading ...
Support Center